Observational studyMedicine2018

Factors predicting 2-year treatment results of ranibizumab therapy for polypoidal choroidal vasculopathy in eyes with good baseline visual acuity.

Ryusaburo Mori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.